Article Information
History
- July 21, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Annabel Klemets1,
- Ingrid Reppo2,3,
- Kertu Liis Krigul1,
- Vallo Volke2,3,
- Oliver Aasmets1,& and
- Elin Org1,&,*
- 1Estonian Genome Centre, Institute of Genomics, University of Tartu, Estonia
- 2Department of Internal Medicine, Institute of Clinical Medicine, University of Tartu, Estonia
- 3Internal Medicine Clinic of Tartu University Hospital, Estonia
- ↵*Corresponding author; email: elin.org{at}ut.ee
↵& These authors contributed equally
Posted July 21, 2024.
Fecal microbiome predicts treatment response after the initiation of semaglutide or empagliflozin uptake
